Nearly a dozen countries resume AstraZeneca shots after EU, UK regulators say benefits outweigh risks By Reuters
By Anthony Deutsch, Toby Sterling and Alistair Smout AMSTERDAM/LONDON (Reuters) - Nearly a dozen countries resumed use of AstraZeneca (NASDAQ:AZN)'s COVID-19 shots on Friday as EU and British regulators said the benefits outweighed any risks after reports of rare instances of blood clotting that temporarily halted inoculations. The end of suspensions will kick off a test of public confidence, both in...
Подробнее